A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Dacarbazine
Defibrotide
The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Defibrotide.
Dacarbazine
Desmoteplase
The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Desmoteplase.
Dacarbazine
Ximelagatran
The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Ximelagatran.
Dacarbazine
Coumarin
The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Coumarin.
Dacarbazine
4-hydroxycoumarin
The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with 4-hydroxycoumarin.
Dacarbazine
Acenocoumarol
The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Acenocoumarol.
Dacarbazine
Epoprostenol
The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Epoprostenol.
Dacarbazine
Enoxaparin
The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Enoxaparin.
Dacarbazine
Heparin
The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Heparin.
Dacarbazine
Phenprocoumon
The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Phenprocoumon.
Dacarbazine
Sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Dasatinib.
Dacarbazine
Roflumilast
Roflumilast may increase the immunosuppressive activities of Dasatinib.
Dacarbazine
Belinostat
The risk or severity of adverse effects can be increased when Dasatinib is combined with Belinostat.
Dacarbazine
Trilostane
The risk or severity of adverse effects can be increased when Trilostane is combined with Dasatinib.
Dacarbazine
Melengestrol
The risk or severity of adverse effects can be increased when Dasatinib is combined with Melengestrol.
Dacarbazine
Fluprednisolone
The risk or severity of adverse effects can be increased when Dasatinib is combined with Fluprednisolone.
Dacarbazine
Vilanterol
The risk or severity of adverse effects can be increased when Dasatinib is combined with Vilanterol.
Dacarbazine
Ciclesonide
The risk or severity of adverse effects can be increased when Dasatinib is combined with Ciclesonide.
Dacarbazine
Temozolomide
The risk or severity of adverse effects can be increased when Temozolomide is combined with Dasatinib.
Dacarbazine
Tetrandrine
The risk or severity of adverse effects can be increased when Tetrandrine is combined with Dasatinib.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3